Since early changes in Aβ metabolism reduce CYFIP2 expression, we studied the phenotype of heterozygous Cyfip2 null mutants in older age, as ageing is the biggest risk factor for AD, and homozygous knockouts are not viable19. The gene discussed is CYFIP2; the disease is Alzheimer disease.